MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION
Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines. One such multi-component vaccine requires a T cell helper component and a toll-like receptor (TLR) agonist. In one embodiment, the inventors...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GAMBHIRA, RATISH ALPHS, HANNAH, H RODEN, RICHARD, B.S |
| description | Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines. One such multi-component vaccine requires a T cell helper component and a toll-like receptor (TLR) agonist. In one embodiment, the inventors described a lipopeptide composition comprising an HPV L2 epitope.
L'invention concerne des procédés et des compositions pour générer une réponse d'anticorps à des épitopes d'HPV utilisant des vaccins multicomposants. Un tel vaccin multicomposant requiert un composant de lymphocyte T auxiliaire et un agoniste de récepteur de type péage (TLR). Dans un mode de réalisation, les inventeurs ont décrit une composition de lipopeptide comprenant un épitope L2 de HPV. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009059328A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009059328A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009059328A33</originalsourceid><addsrcrecordid>eNqNysEKAiEUQFE3LaL6hwetB0QJmqWIMoK-J6bOchjCVlED0_9TQR_Q6sLlbJkPxWfXgaYQCQ1m8AKq0tqhAUsJYjL1sx0hkIWhBIUQVXTeU1DVpXIBh9bor9izzW2-r-3w644drcl66NrynNq6zNf2aK9pJMF5z0-9FGcl5X_qDXfzLws</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION</title><source>esp@cenet</source><creator>GAMBHIRA, RATISH ; ALPHS, HANNAH, H ; RODEN, RICHARD, B.S</creator><creatorcontrib>GAMBHIRA, RATISH ; ALPHS, HANNAH, H ; RODEN, RICHARD, B.S</creatorcontrib><description>Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines. One such multi-component vaccine requires a T cell helper component and a toll-like receptor (TLR) agonist. In one embodiment, the inventors described a lipopeptide composition comprising an HPV L2 epitope.
L'invention concerne des procédés et des compositions pour générer une réponse d'anticorps à des épitopes d'HPV utilisant des vaccins multicomposants. Un tel vaccin multicomposant requiert un composant de lymphocyte T auxiliaire et un agoniste de récepteur de type péage (TLR). Dans un mode de réalisation, les inventeurs ont décrit une composition de lipopeptide comprenant un épitope L2 de HPV.</description><language>eng ; fre</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160526&DB=EPODOC&CC=WO&NR=2009059328A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160526&DB=EPODOC&CC=WO&NR=2009059328A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GAMBHIRA, RATISH</creatorcontrib><creatorcontrib>ALPHS, HANNAH, H</creatorcontrib><creatorcontrib>RODEN, RICHARD, B.S</creatorcontrib><title>MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION</title><description>Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines. One such multi-component vaccine requires a T cell helper component and a toll-like receptor (TLR) agonist. In one embodiment, the inventors described a lipopeptide composition comprising an HPV L2 epitope.
L'invention concerne des procédés et des compositions pour générer une réponse d'anticorps à des épitopes d'HPV utilisant des vaccins multicomposants. Un tel vaccin multicomposant requiert un composant de lymphocyte T auxiliaire et un agoniste de récepteur de type péage (TLR). Dans un mode de réalisation, les inventeurs ont décrit une composition de lipopeptide comprenant un épitope L2 de HPV.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNysEKAiEUQFE3LaL6hwetB0QJmqWIMoK-J6bOchjCVlED0_9TQR_Q6sLlbJkPxWfXgaYQCQ1m8AKq0tqhAUsJYjL1sx0hkIWhBIUQVXTeU1DVpXIBh9bor9izzW2-r-3w644drcl66NrynNq6zNf2aK9pJMF5z0-9FGcl5X_qDXfzLws</recordid><startdate>20160526</startdate><enddate>20160526</enddate><creator>GAMBHIRA, RATISH</creator><creator>ALPHS, HANNAH, H</creator><creator>RODEN, RICHARD, B.S</creator><scope>EVB</scope></search><sort><creationdate>20160526</creationdate><title>MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION</title><author>GAMBHIRA, RATISH ; ALPHS, HANNAH, H ; RODEN, RICHARD, B.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009059328A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>GAMBHIRA, RATISH</creatorcontrib><creatorcontrib>ALPHS, HANNAH, H</creatorcontrib><creatorcontrib>RODEN, RICHARD, B.S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GAMBHIRA, RATISH</au><au>ALPHS, HANNAH, H</au><au>RODEN, RICHARD, B.S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION</title><date>2016-05-26</date><risdate>2016</risdate><abstract>Embodiments of the invention are directed to methods and compositions for generating an antibody response against HPV epitopes using multi-component vaccines. One such multi-component vaccine requires a T cell helper component and a toll-like receptor (TLR) agonist. In one embodiment, the inventors described a lipopeptide composition comprising an HPV L2 epitope.
L'invention concerne des procédés et des compositions pour générer une réponse d'anticorps à des épitopes d'HPV utilisant des vaccins multicomposants. Un tel vaccin multicomposant requiert un composant de lymphocyte T auxiliaire et un agoniste de récepteur de type péage (TLR). Dans un mode de réalisation, les inventeurs ont décrit une composition de lipopeptide comprenant un épitope L2 de HPV.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2009059328A3 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | MULTI- COMPONENT L2 VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T12%3A02%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GAMBHIRA,%20RATISH&rft.date=2016-05-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009059328A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |